Myeloma
SOHO 4th Italian Conference
SOHO Italy 2022: New Insights in hBMMSC Migration - The Response to Plasma Bone Marrow and the Role of IRE1a
FEATURING
Francesco Da Ros
- 21 views
- December 6, 2022
SOHO 4th Italian Conference
SOHO Italy 2022: Ferroptosis as a New Off-Target Effect of BCMA-Targeted IO in MM
FEATURING
Enrico La Spina
- 12 views
- December 6, 2022
SOHO 4th Italian Conference
SOHO Italy 2022: SRY-Box Transcription Factor 4 as a Target for MM New Therapeutic Strategy
FEATURING
Elisabetta Lombardi
- 14 views
- December 6, 2022
SOHO 4th Italian Conference
SOHO Italy 2022: Therapy-Related Myeloid Neoplasm After Multiple Myeloma in the Area of New Drugs
FEATURING
Laura Cicconi
- 9 views
- December 6, 2022
SOHO 4th Italian Conference
SOHO Italy 2022: Artificial Intelligence - Applications in MM
FEATURING
Adrián Mosquera Orgueira
- 23 views
- November 30, 2022
SOHO 4th Italian Conference
SOHO Italy 2022: MM State-of-the-Art in Europe
FEATURING
Claudio Cerchione
- 23 views
- November 30, 2022
Philippe Moreau
EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-Up in MM: What Is Changing?
- 83 views
- November 30, 2022
- 1
SOHO 4th Italian Conference
SOHO Italy 2022: How I Treat Extramedullary Disease and Plasma Cell Leukemia
FEATURING
Daniele Derudas
- 47 views
- November 30, 2022
SOHO 4th Italian Conference
SOHO Italy 2022 on the MRD Assessment in MM: Should We? When? Why?
FEATURING
Carolina Terragna
- 21 views
- November 30, 2022
- 1
SOHO 4th Italian Conference
SOHO Italy 2022 on the Genomics of Smoldering MM: Time for Clinical Translation of Findings?
FEATURING
Niccolo Bolli
- 19 views
- November 30, 2022
Kenneth Anderson
MM Cured in 2030 - What Are the Next Steps?
FEATURING
Kenneth Anderson
- 592 views
- November 30, 2022
- 6
SOHO 4th Italian Conference
SOHO Italy 2022: Next Questions in MM
FEATURING
Claudio Cerchione
- 56 views
- November 24, 2022